Private Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-662
Closed -$267K 136
2015
Q2
$267K Hold
662
0.04% 120
2015
Q1
$280K Hold
662
0.05% 120
2014
Q4
$225K Hold
662
0.04% 129
2014
Q3
$219K Sell
662
-100
-13% -$33K 0.04% 133
2014
Q2
$240K Sell
762
-20
-3% -$6.02K 0.04% 123
2014
Q1
$239K Hold
782
0.04% 123
2013
Q4
$219K Buy
+782
New +$202K 0.04% 126
2013
Q3
Sell
-1,057
Closed -$227K 138
2013
Q2
$227K Buy
+1,057
New +$226K 0.04% 136

Other funds holding BIIB

Private Asset Management's BIIB Position: Q3 2015 in Review

Private Asset Management sold out of Biogen (BIIB) in Q3 2015, closing a stake of 662 shares — an estimated $267K sold.

Private Asset Management first reported a position in BIIB in Q2 2013 and held it in 8 quarters. The position peaked at $280K in Q1 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Private Asset Management reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Private Asset Management sold 662 Biogen shares in Q3 2015, an estimated $267K.
  • Private Asset Management first reported a position in Biogen in Q2 2013 and held it in 8 quarters.
  • Private Asset Management's Biogen position peaked at $280K in Q1 2015.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Private Asset Management's 13F filing for Q3 2015, filed 9 Oct 2015.